Back to search
FDAFDA · Food and drugs·Recall number D-171-2013

Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-327-09

Published March 6, 2013 · Recall initiated: December 4, 2012

Summary

FDA records drug Class II recall D-171-2013, published March 6, 2013 and initiated December 4, 2012. Recalling firm: Amedra Pharmaceuticals LLC; Status: Terminated; Reported quantity: 1,176 bottles; Lot: Lot 238316, exp 01/31/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amedra Pharmaceuticals LLC
Distributor
Nationwide and Puerto Rico.
Lot
Lot 238316, exp 01/31/2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by Catalent Pharma Solutions for CorePharma, LLC Middlesex, NJ 08846 NDC 64720-327-09 recalled?

Yes. FDA published recall D-171-2013 on March 6, 2013. Reported hazard: Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.

What should I do if I have this product?

Voluntary: Firm initiated · Letter